Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Computerized analysis of retinal vascular growth following intravitreal bevacizumab monotherapy in retinopathy of prematurity until the age of three years

Jon David Hammer; Henry Nguyen; Jacqueline Palmer; Sarah Rowlinson; Swati Agarwal-Sinha

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3242. doi:

ARVO Annual Meeting Abstract June 2020

Angiographic review of Choroidal Involution in eyes with Retinopathy of Prematurity post Bevacizumab treatment

Lorick Andersen; Yasmin Islam; Swati Agarwal-Sinha

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2764. doi:

ARVO Annual Meeting Abstract June 2020

Correlation of central corneal thickness and associated factors in premature infants with and without retinopathy of prematurity

Yasmin Islam; Wei Xue; Swati Agarwal-Sinha

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2157. doi:

ARVO Annual Meeting Abstract July 2018

Aflibercept does not inhibit normal retinal vascular development in the mouse model of oxygen-induced retinopathy

Jade Gieseke Gieseke Guevara; Andres Gonzalez; Clay Clay Smith; Swati Agarwal-Sinha; Sarina Amin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):772. doi:

ARVO Annual Meeting Abstract July 2018

Fluorescein angiography findings post intravitreal bevacizumab for Retinopathy of Prematurity: Can it predict the late-onset risk of recurrence?

Swati Agarwal-Sinha; Andres Gonzales

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2746. doi:

ARVO Annual Meeting Abstract July 2018

Pilot Study on the Educational Value of a Retinopathy of Prematurity Clinical Immersion Training Program for Ophthalmology Residents

Andres Gonzalez; Sarina Amin; Swati Agarwal-Sinha

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2778. doi:

Advertisement